Table 2 Percentages of individuals with and without antibodies in each district
Type of antibody | District | Percentage seropositives | Percentage seronegatives | Chi | p |
|---|---|---|---|---|---|
MSP1-19_Pf | Kurunegala | 25.7 | 74.3 | 50.68 | < 0.05 |
| Â | Moneragala | 71.7 | 28.3 | Â | Â |
| Â | Males | 72.1 | 27.9 | 22.783 | <0.05 |
| Â | Females | 36.9 | 63.1 | Â | Â |
MSP1-19_Pv | Kurunegala | 55.1 | 44.9 | 27.89 | < 0.05 |
| Â | Moneragala | 86.8 | 13.2 | Â | Â |
| Â | Males | 77.0 | 23.0 | 2.622 | 0.105 |
| Â | Females | 65.9 | 34.1 | Â | Â |
AMA1_Pf | Kurunegala | 83.1 | 16.9 | 7.60 | 0.006 |
| Â | Moneragala | 67.9 | 32.1 | Â | Â |
| Â | Males | 77.0 | 23.0 | 0.029 | 0.865 |
| Â | Females | 76.0 | 24.0 | Â | Â |
AMA1_Pv | Kurunegala | 68.4 | 31.6 | 13.97 | < 0.05 |
| Â | Moneragala | 88.7 | 11.3 | Â | Â |
| Â | Males | 85.2 | 14.8 | 3.085 | 0.079 |
| Â | Females | 74.3 | 25.7 | Â | Â |